{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:36:50Z","timestamp":1768365410825,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ANR","award":["This research was funded by prematurity PoC in labs program (Universit\u00e9 Paris-Saclay, 2016-2018) and Agence Nationale de la Recherche [ANR-23-CE18-0022]."],"award-info":[{"award-number":["This research was funded by prematurity PoC in labs program (Universit\u00e9 Paris-Saclay, 2016-2018) and Agence Nationale de la Recherche [ANR-23-CE18-0022]."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study reports a new therapeutic approach for canine giardiasis, the most common intestinal protozoan infection caused by\n                    <jats:italic>Giardia intestinalis<\/jats:italic>\n                    . It is based on the use of the probiotic strain\n                    <jats:italic>Lactobacillus johnsonii<\/jats:italic>\n                    CNCM I-4884 and, in particular, its bile salt hydrolase enzymatic activities. Clinical trials in dogs demonstrated that daily administration of\n                    <jats:italic>L. johnsonii<\/jats:italic>\n                    CNCM I-4884 significantly reduced\n                    <jats:italic>Giardia<\/jats:italic>\n                    cyst shedding after 14\u00a0days. These results highlight the potential of this probiotic as a promising alternative to antimicrobials, such as nitroimidazoles or benzimidazoles, for the treatment of giardiasis in dogs. Moreover, they provide a novel approach for the veterinary industry to develop innovative products targeting this parasite. In addition to its direct anti-\n                    <jats:italic>Giardia<\/jats:italic>\n                    effect,\n                    <jats:italic>L. johnsonii<\/jats:italic>\n                    CNCM I-4884 may also act as an adjuvant therapy, supporting intestinal homeostasis, enhancing host defense mechanisms, and promoting recovery of gut balance during or after antiparasitic treatments. This dual role suggests that the strain could be considered not only as a complementary therapy but, in specific cases, as a potential stand-alone probiotic treatment for canine giardiasis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13071-025-07166-3","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T14:43:40Z","timestamp":1765032220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Lactobacillus johnsonii CNCM I-4884 on canine giardiasis: a probiotic-based approach"],"prefix":"10.1186","volume":"19","author":[{"given":"Bruno","family":"Polack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Wu-Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianet","family":"Abuin-Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Cabezas-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Jacouton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mammeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Florent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Berm\u00fadez-Humar\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"7166_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007250","volume":"14","author":"L Cernikova","year":"2018","unstructured":"Cernikova L, Faso C, Hehl AB. Five facts about Giardia lamblia. PLoS Pathog. 2018;14:e1007250. https:\/\/doi.org\/10.1371\/journal.ppat.1007250.","journal-title":"PLoS Pathog"},{"key":"7166_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00024-19","volume":"34","author":"RD Adam","year":"2021","unstructured":"Adam RD. Giardia duodenalis: biology and pathogenesis. Clin Microbiol Rev. 2021;34:e0002419. https:\/\/doi.org\/10.1128\/CMR.00024-19.","journal-title":"Clin Microbiol Rev"},{"key":"7166_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.meegid.2017.12.001","volume":"66","author":"SM Caccio","year":"2018","unstructured":"Caccio SM, Lalle M, Svard SG. Host specificity in the Giardia duodenalis species complex. Infect Genet Evol. 2018;66:335\u201345. https:\/\/doi.org\/10.1016\/j.meegid.2017.12.001.","journal-title":"Infect Genet Evol"},{"key":"7166_CR4","doi-asserted-by":"publisher","first-page":"101878","DOI":"10.1016\/j.cimid.2022.101878","volume":"89","author":"A Silva","year":"2022","unstructured":"Silva A, Martins FDC, Ladeia WA, Kakimori MTA, Lucas JI, Sasse JP, et al. First report of Giardia duodenalis assemblage F in humans and dogs in southern Brazil. Comp Immunol Microbiol Infect Dis. 2022;89:101878. https:\/\/doi.org\/10.1016\/j.cimid.2022.101878.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"7166_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/bs.apar.2019.11.003","volume":"107","author":"R Arguello-Garcia","year":"2020","unstructured":"Arguello-Garcia R, Leitsch D, Skinner-Adams T, Ortega-Pierres MG. Drug resistance in Giardia: mechanisms and alternative treatments for giardiasis. Adv Parasitol. 2020;107:201\u201382. https:\/\/doi.org\/10.1016\/bs.apar.2019.11.003.","journal-title":"Adv Parasitol"},{"key":"7166_CR6","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2147\/IDR.S141468","volume":"11","author":"M Lalle","year":"2018","unstructured":"Lalle M, Hanevik K. Treatment-refractory giardiasis: challenges and solutions. Infect Drug Resist. 2018;11:1921\u201333. https:\/\/doi.org\/10.2147\/IDR.S141468.","journal-title":"Infect Drug Resist"},{"key":"7166_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.vetpar.2014.12.011","volume":"207","author":"M Bouzid","year":"2015","unstructured":"Bouzid M, Halai K, Jeffreys D, Hunter PR. The prevalence of Giardia infection in dogs and cats, a systematic review and meta-analysis of prevalence studies from stool samples. Vet Parasitol. 2015;207:181\u2013202. https:\/\/doi.org\/10.1016\/j.vetpar.2014.12.011.","journal-title":"Vet Parasitol"},{"key":"7166_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/QCO.0000000000000668","volume":"33","author":"K Morch","year":"2020","unstructured":"Morch K, Hanevik K. Giardiasis treatment: an update with a focus on refractory disease. Curr Opin Infect Dis. 2020;33:355\u201364. https:\/\/doi.org\/10.1097\/QCO.0000000000000668.","journal-title":"Curr Opin Infect Dis"},{"key":"7166_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1051\/parasite\/2022048","volume":"29","author":"H Kaufmann","year":"2022","unstructured":"Kaufmann H, Zenner L, Benabed S, Poirel MT, Bourgoin G. Lack of efficacy of fenbendazole against Giardia duodenalis in a naturally infected population of dogs in France. Parasite. 2022;29:49. https:\/\/doi.org\/10.1051\/parasite\/2022048.","journal-title":"Parasite"},{"key":"7166_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/610769","volume":"2011","author":"MA Travers","year":"2011","unstructured":"Travers MA, Florent I, Kohl L, Grellier P. Probiotics for the control of parasites: an overview. J Parasitol Res. 2011;2011:610769. https:\/\/doi.org\/10.1155\/2011\/610769.","journal-title":"J Parasitol Res"},{"key":"7166_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3389\/fmicb.2018.00089","volume":"9","author":"T Allain","year":"2018","unstructured":"Allain T, Chaouch S, Thomas M, Travers MA, Valle I, Langella P, et\u00a0al. Bile salt hydrolase activities: a novel target to screen anti-Giardia lactobacilli? Front Microbiol. 2018;9:89. https:\/\/doi.org\/10.3389\/fmicb.2018.00089.","journal-title":"Front Microbiol"},{"key":"7166_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01453","volume":"7","author":"MA Travers","year":"2016","unstructured":"Travers MA, Sow C, Zirah S, Deregnaucourt C, Chaouch S, Queiroz RM, et\u00a0al. Deconjugated bile salts produced by extracellular bile-salt hydrolase-like activities from the probiotic Lactobacillus johnsonii La1 inhibit Giardia duodenalis in vitro growth. Front Microbiol. 2016;7:1453. https:\/\/doi.org\/10.3389\/fmicb.2016.01453.","journal-title":"Front Microbiol"},{"key":"7166_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02707","volume":"8","author":"T Allain","year":"2017","unstructured":"Allain T, Chaouch S, Thomas M, Vallee I, Buret AG, Langella P, et\u00a0al. Bile-salt-hydrolases from the probiotic strain Lactobacillus johnsonii La1 mediate anti-giardial activity in vitro and in vivo. Front Microbiol. 2017;8:2707. https:\/\/doi.org\/10.3389\/fmicb.2017.02707.","journal-title":"Front Microbiol"},{"key":"7166_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054335","volume":"8","author":"C Mayeur","year":"2013","unstructured":"Mayeur C, Gratadoux JJ, Bridonneau C, Chegdani F, Larroque B, Kapel N, et\u00a0al. Faecal D\/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS ONE. 2013;8:e54335. https:\/\/doi.org\/10.1371\/journal.pone.0054335.","journal-title":"PLoS ONE"},{"key":"7166_CR15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et\u00a0al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37:852\u20137. https:\/\/doi.org\/10.1038\/s41587-019-0209-9.","journal-title":"Nat Biotechnol"},{"key":"7166_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581\u20133. https:\/\/doi.org\/10.1038\/nmeth.3869.","journal-title":"Nat Methods"},{"key":"7166_CR17","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/nar\/gkf436","volume":"30","author":"K Katoh","year":"2002","unstructured":"Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002;30:3059\u201366. https:\/\/doi.org\/10.1093\/nar\/gkf436.","journal-title":"Nucleic Acids Res"},{"key":"7166_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009490","volume":"5","author":"MN Price","year":"2010","unstructured":"Price MN, Dehal PS, Arkin AP. FastTree 2--Approximately maximum-likelihood trees for large alignments. PLoS ONE. 2010;5:e9490. https:\/\/doi.org\/10.1371\/journal.pone.0009490.","journal-title":"PLoS ONE"},{"key":"7166_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrmicro3330","volume":"12","author":"P Yarza","year":"2014","unstructured":"Yarza P, Yilmaz P, Pruesse E, Glockner FO, Ludwig W, Schleifer KH, et\u00a0al. Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nat Rev Microbiol. 2014;12:635\u201345. https:\/\/doi.org\/10.1038\/nrmicro3330.","journal-title":"Nat Rev Microbiol"},{"key":"7166_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.chom.2013.06.007","volume":"14","author":"E Deriu","year":"2013","unstructured":"Deriu E, Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H, et\u00a0al. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe. 2013;14:26\u201337. https:\/\/doi.org\/10.1016\/j.chom.2013.06.007.","journal-title":"Cell Host Microbe"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07166-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-07166-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07166-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:15:46Z","timestamp":1768342546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-025-07166-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7166"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-07166-3","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical trial was performed under the approval and oversight of the local ethical committee for clinical research of the Ecole Nationale V\u00e9t\u00e9rinaire d\u2019Alfort (approval no. ComERC 2017-10-20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A.C-C. and L.G.B-H. are co-founders of microXpace. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors provide this consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"22"}}